SIMULCONSULT, INC.
diagnostic decision support software for pediatric rheumatology that assists generalist physicians in making rheumatologic diagnoses
- Sector
- Digital health
- Headquarters
- BROOKLINE, MA
- Founded
- 2008
- Latest Form D
- $405K, Jul 2023
- Total capital
- $1M
- Federal grants
- $581K
- 2 awards · 2015–2017
- Sector median 0 awards
- Private capital raised
- $455K
- 2 Form D · last Jul 2023
- 39 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- 6 pending · first 2016
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$405K
- Federal grantHealth and Human S · Phase II · Testing Pediatric Rheumatology Diagnostic Decision Support in Clinical Use$175K
- Federal grantHealth and Human S · Phase II · Extending Genome-Phenome Analysis$407K
- Private capital raisedForm D · SEC · 1st filing$50K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
Researcher links verified by same-company patents and grants- Michael SegalResearcherExecutive Officer, DirectorLinked by 1 patent · $581K in grants as PI
- Lynn FeldmanExecutive Officer, Director, PromoterNamed in SEC Form D filings
- Rick BerensonExecutive OfficerNamed in SEC Form D filings
- Zbikowski MarkExecutive OfficerNamed in SEC Form D filings
What it has protected
USPTO · 1 granted of 7- PendingMethod And System For Collecting, Recording, And Transmitting Clinical Information With Usefulness-driven PromptsUSPTOApplication 18696720
- PendingMethod And System For Incorporating Patient InformationUSPTOApplication 17797559
- GrantedGenome-phenome Analyzer And Methods Of Using SameUSPTOUS 9,524,373
Show all 7 patent records
- Method And System For Collecting, Recording, And Transmitting Clinical Information With Usefulness-driven PromptsNov 14, 2024 · Application 18696720Pending
- Method And System For Incorporating Patient InformationMar 9, 2023 · Application 17797559Pending
- Genome-phenome Analyzer And Methods Of Using SameDec 20, 2016 · US 9,524,373Granted
- Method And System For Incorporating Patient InformationApplication 62970847Pending
- Method And System For Collecting, Recording, And Transmitting Clinical Information With Usefulness-driven PromptsApplication 63249675Pending
- Method And System For Collecting, Recording, And Transmitting Clinical Information With Usefulness-driven PromptsApplication PCTUS2022045276Pending
- Method And System For Incorporating Patient InformationApplication PCTUS2021017027Pending
Recent research by its founders
- Lidocaine Ineffectiveness Suggests New Psychopharmacology Drug Target20251 cites
- Abstract No. 531 Novel, Injectable, Biocompatible, and Tunable Polymer for Vertebral Augmentation20250 cites
- Computer Resources, Artificial Intelligence, and Telemedicine20250 cites
Regulatory activity · Digital health
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .